Johnson & Johnson on Monday said it received three subpoenas from U.S. attorneys related to sales and marketing of three of its prescription drugs.
The drugmaker said the subpoenas, from the U.S. Attorneys in Philadelphia, Boston and San Francisco, relate to previously disclosed probes over the company's oversight of three of its subsidiaries.
The drugs being investigated are Risperdal, Topamax, and Natrecor.
Source: Reuters
No comments:
Post a Comment